This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05245695
Recruitment Status : Recruiting
First Posted : February 18, 2022
Last Update Posted : February 16, 2024
Sponsor:
Information provided by (Responsible Party):
Aspira Women's Health

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The goal of this observational study is to determine the clinical validity of a deep neural network algorithm that utilizes protein biomarker detection of Endometriosis - "EndoCheck" - as an "aid in diagnosis" for endometriosis and to show validity as a diagnostic test

Condition or disease Intervention/treatment
Endometriosis Other: Observational study, no intervention

Detailed Description:

The objective is to confirm the clinical performance (sensitivity and specificity) of EndoCheck when compared to laparoscopic surgical assessment as an "aid in diagnosis" for endometriosis in subjects who present with chronic pelvic pain.

The primary endpoint of the study is to optimize the test to achieve the success criteria of at least 94% and 79% sensitivity and specificity, respectively. Secondary endpoints include examining the performance of the test in patients stratified by pain severity and other clinical factors.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 600 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Deep Neural Network Stratification for the Use in Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
Actual Study Start Date : July 12, 2022
Estimated Primary Completion Date : July 31, 2024
Estimated Study Completion Date : July 31, 2024

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Intervention Details:
  • Other: Observational study, no intervention
    Observational study, no intervention

Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Sensitivity and Specificity [ Time Frame: 24 months ]
    The primary endpoint of the study is to optimize the test to achieve the success criteria of at least 94% and 79% sensitivity and specificity, respectively


Secondary Outcome Measures :
  1. Performance [ Time Frame: 24 months ]
    Examining the performance of the test in patients stratified by pain severity and other clinical factors.


Biospecimen Retention:   Samples With DNA
Serum Cell-free DNA

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years to 50 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Women scheduled for a gynecologic surgery
Criteria

Inclusion Criteria:

  • Participant is willing and able to provide written informed consent.
  • Participant is a female aged 14 to 50 years old at time of consent.
  • Participant is scheduled to undergo laparotomy or laparoscopy secondary to chronic pain associated with suspected endometriosis.

Exclusion Criteria:

  • Participant has a history of surgically determined diagnosis of endometriosis (either via visual inspection or histopathology).
  • Participant is a female in a pre-menarchal state.
  • Participant is pregnant.
  • Participant has an active malignancy.
  • Participant is known to have tested positive for human immunodeficiency virus or hepatitis A, B, or C.
  • Participant has an active pelvic infection or other infections contraindicated for surgery.
  • Participant has participated (±3 months of study enrollment) in a clinical trial where an investigational drug/ device/ procedure was or is planned to be administered.
  • Participant has any general health or behavioral condition that, in the opinion of the investigator, should exclude the participant from participation.
  • Participant is under 14 years old or over 50 years old
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05245695


Contacts
Layout table for location contacts
Contact: Silvana Franco 844-277-4721 sfranco@aspirawh.com
Contact: Allison Jarosz ajarosz@aspirawh.com

Locations
Layout table for location information
United States, Arizona
New Horizons Clinical Trials Recruiting
Chandler, Arizona, United States, 852224
Contact: Saira Flores, MD       sflores@aoafamily.com   
Contact    (480) 496-2236      
Principal Investigator: Monte Swarup         
Arizona Gynecology Consultants Recruiting
Mesa, Arizona, United States, 85203
Contact: Kristina Calligan       kcalligan@azgyn.com   
Principal Investigator: Kelly Roy, MD         
United States, Delaware
Reproductive Associates of Delaware (RAD) Recruiting
Newark, Delaware, United States, 19713
Contact: Eileen Davies       edavies@radfertility.com   
Principal Investigator: Ronald Feinberg         
United States, Georgia
Midtown OBGYN North Recruiting
Columbus, Georgia, United States, 31909
Contact: Rebecca Watkins       rebeccaw@midtownob.com   
Principal Investigator: Serena Tidwell         
Advanced Women's Care Center Recruiting
Stockbridge, Georgia, United States, 30281
Contact: Dana Smith, MD    770-538-1723    dana@advancedwomenscarecenter.com   
Principal Investigator: Tamika Sea, MD         
United States, New York
Nezhat Surgery for Gynecology/Oncology Recruiting
Valley Stream, New York, United States, 11581
Contact: Esra Demirel       esra@farrnezhatmd.com   
Principal Investigator: Farr Nezhat, MD         
United States, Ohio
Axia Women's Health Recruiting
Cincinnati, Ohio, United States, 45242
Contact: Brigette Tillman       brigette.tillman@axiawh.com   
Principal Investigator: Gerard Reilly         
United States, Pennsylvania
May Grant Recruiting
Lancaster, Pennsylvania, United States, 17601
Contact: Aelxa Trimble       alexamish5@gmail.com   
Principal Investigator: Kent Meldrum         
United States, Virginia
Womens Health Services of Central Virginia Recruiting
Lynchburg, Virginia, United States, 24502
Contact: Whittney Critchley    434-485-7059      
Principal Investigator: Wade Neiman         
Sponsors and Collaborators
Aspira Women's Health
Investigators
Layout table for investigator information
Principal Investigator: Todd Pappas, PhD Aspira Women's Health
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Layout table for additonal information
Responsible Party: Aspira Women's Health
ClinicalTrials.gov Identifier: NCT05245695    
Other Study ID Numbers: 12-2021
First Posted: February 18, 2022    Key Record Dates
Last Update Posted: February 16, 2024
Last Verified: February 2024
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Aspira Women's Health:
Endometriosis
Biomarkers
Deep neural network
Additional relevant MeSH terms:
Layout table for MeSH terms
Endometriosis
Pelvic Pain
Genital Diseases, Female
Female Urogenital Diseases
Female Urogenital Diseases and Pregnancy Complications
 Urogenital Diseases
Genital Diseases
Pain
Neurologic Manifestations